Future Technology
The nanobot will have the capability
to be used for two different purposes. One will be an Anti-Virus DNA nanobot that
can treat and prevent the spread of specific virulent viral diseases. The other
is an Anti-Sense DNA nanobot that can be used to replace the mutated genes with
functional genes to control genetic disorders. Both nanobots will use programmed
Deoxyribonucleic acid (DNA) to restructure the mutated gene DNA and the viral DNA
structures.
The nanobot will be non-immunogenic which means that it will not induce any specific immune response in the body that it is injected into because the two main components of the nanobot, the DNA molecules and liposomes are non-immunogenic by themselves. The nanobot’s structure will be composed of programmed DNA molecules encased by two layers of lipid-soluble material such as liposomes. The nanobots function at the cell-nuclear level.
The human cell membrane is mainly composed of phospholipid, glycolipid, trans membrane protein, glycoprotein, cholesterol and carbohydrates. The nuclear membrane is mainly composed of nuclear envelope and the outer and inner membranes that are phospholipid bilayers. When the nanobot comes in contact with the target cell, it functions at two levels. At each of its level of operation, each of its liposome layers dissolve as it diffuses through the cell membrane and the nuclear membrane. The programmed DNA of the nanobot now binds with the target cell DNA in the nucleoplasm. The nanobot DNA can then alter the targeted DNA structure. The nanobot disintegrates biologically along with the cell it is bound with. The number of nanobots injected into the body will depend upon the severity of the viral infection and gene mutation.
The Anti-Virus DNA nanobot modifies the structure of the viral DNA in the nucleoplasm thus hindering or blocking the process of virus replication within the cell. This nanobot can also operate outside the cell in order to make the virus noninfectious. This is a one level process only. Capsid of a virus is a protein layer around the viral DNA. Envelope around the capsid is a lipid layer with glycoproteins that facilitate the virus to bind to the host cell. When the Anti-Virus DNA nanobot comes in contact with the target virus, its steroid layers allow the nanobot to diffuse through the lipid envelope and/or capsid of the virus. The nanobot DNA comes in contact with the viral DNA and changes its structure thus making it noninfectious.
The Anti-Sense DNA nanobot diffuses through the cell membrane and nuclear membrane of the target cell thus allowing the nanobot DNA to bind with the mutated gene in the particular gene location. The mutated gene structure is now replaced by the nanobot DNA.
The nanobot will be non-immunogenic which means that it will not induce any specific immune response in the body that it is injected into because the two main components of the nanobot, the DNA molecules and liposomes are non-immunogenic by themselves. The nanobot’s structure will be composed of programmed DNA molecules encased by two layers of lipid-soluble material such as liposomes. The nanobots function at the cell-nuclear level.
The human cell membrane is mainly composed of phospholipid, glycolipid, trans membrane protein, glycoprotein, cholesterol and carbohydrates. The nuclear membrane is mainly composed of nuclear envelope and the outer and inner membranes that are phospholipid bilayers. When the nanobot comes in contact with the target cell, it functions at two levels. At each of its level of operation, each of its liposome layers dissolve as it diffuses through the cell membrane and the nuclear membrane. The programmed DNA of the nanobot now binds with the target cell DNA in the nucleoplasm. The nanobot DNA can then alter the targeted DNA structure. The nanobot disintegrates biologically along with the cell it is bound with. The number of nanobots injected into the body will depend upon the severity of the viral infection and gene mutation.
The Anti-Virus DNA nanobot modifies the structure of the viral DNA in the nucleoplasm thus hindering or blocking the process of virus replication within the cell. This nanobot can also operate outside the cell in order to make the virus noninfectious. This is a one level process only. Capsid of a virus is a protein layer around the viral DNA. Envelope around the capsid is a lipid layer with glycoproteins that facilitate the virus to bind to the host cell. When the Anti-Virus DNA nanobot comes in contact with the target virus, its steroid layers allow the nanobot to diffuse through the lipid envelope and/or capsid of the virus. The nanobot DNA comes in contact with the viral DNA and changes its structure thus making it noninfectious.
The Anti-Sense DNA nanobot diffuses through the cell membrane and nuclear membrane of the target cell thus allowing the nanobot DNA to bind with the mutated gene in the particular gene location. The mutated gene structure is now replaced by the nanobot DNA.